The assessment of pharmacoeconomic studies quality of Levodopa’s use for the management of Parkinson’s diseases, 2010-2015
Levodopa (LD) has been the first choice in the management of Parkinson’s disease(PD), since its introduction in the drug market; however, its prolonged use is related tothe occurrence of motor complications, affecting the functionality and quality of life.Parkinson’s disease is one of the most frequ...
- Autores:
-
Hermida Gutiérrez, Nelson H.
Sanabria Becerra, Lina M.
Díaz Rojas, Jorge A.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2017
- Institución:
- Universidad Nacional de Colombia
- Repositorio:
- Universidad Nacional de Colombia
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.unal.edu.co:unal/66589
- Acceso en línea:
- https://repositorio.unal.edu.co/handle/unal/66589
http://bdigital.unal.edu.co/67617/
- Palabra clave:
- 66 Ingeniería química y Tecnologías relacionadas/ Chemical engineering
61 Ciencias médicas; Medicina / Medicine and health
Levodopa
Parkinson’s disease
cost-utility
methodological quality
QHES (Quality of Health Economic Studies)
Levodopa
enfermedad de Parkinson
costo-utilidad
calidad metodológica
QHES (Quality of Health Economic Studies)
- Rights
- openAccess
- License
- Atribución-NoComercial 4.0 Internacional